6 employees
ProThera Biologics focuses on unmet medical needs by developing integrated theranostic and therapeutic biomolecules.
2001
$750K
from 2 investors over 2 rounds
ProThera Biologics raised $750K on September 5, 2012
Investors: Slater Technology Fund and National Institutes of Health